Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers
نویسندگان
چکیده
منابع مشابه
Menstrual Cycle Dependent Variability for Serum Tumor Markers CEA, AFP, CA 19-9, CA 125 and CA 15-3 in Healthy Women
Information on menstrual cycle dependent variation of tumor markers in healthy women is a subject of diagnostic efficiency and has an impact in elucidating the normal function of these markers. In this study midfollicular and midluteal concentrations of serum CEA, AFP, CA 19-9, CA 125, CA 15-3 and their relations with LH, FSH, prolactin, estradiol and progesterone were evaluated during ovulator...
متن کاملThe utility of tumor markers CA 125, CA 15-3, and CA 19-9 in assessing the response to therapy in pulmonary and pleural tuberculosis
AIM Both of the diagnosis and treatment evaluation are time-consuming conditions in patients with pulmonary and pleural tuberculosis. The aim of this study was to establish the validity of tumor markers CA 125, CA 15-3, and CA 19-9 in the diagnosis of pulmonary and pleural TB and to verify the success of the treatment protocol. PATIENTS AND METHODS The levels of tumor markers CA 125, CA 15-3,...
متن کاملthe prognosticrole of tumor marker ca-125 in b-cell
background: b-cell non-hodgkin’s lymphoma (nhl) is a common malignancy of lymphoid tissues. different types of nhl show various behaviors, prognoses, and responses to treatment. evaluation of disease activity in nhl can be helpful in managing and even increasing the patient’s survey. methods and results: in total, 121 patients (76 males and 45 females), and their age range were 18-53 years, wer...
متن کاملبررسی ارزش تشخیصی میزان CA 125, CA 19-9, CA 15-3 مایع پلور در افتراق افیوژن پلورال بدخیم از خوش‌خیم
Background and purpose : Malignant and infectious diseases are the most frequent causes of pleural effusion. Malignant diseases produce pleural effusion through different mechanisms: lymphatic and capillary obstruction, pneumonia or atelectasia. Therefore absence of tumor cells in aspirated effusion, highly declines the sensivity of the cytologic study. For this reason, the use of tumor marke...
متن کاملTumor marker CA 15-3 in breast cancer patients.
OBJECTIVE The aim of this study was to determine whether there is a correlation between the serum concentration of the tumor marker CA 15-3 and breast cancer, which has not been proven by the existence of regional and distant metastases, and breast cancer with the presence of regional and distant metastases. PATIENTS AND METHODS The study was a retrospective-prospective study, and was conduct...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Tumor Biology
سال: 2017
ISSN: 1010-4283,1423-0380
DOI: 10.1177/1010428317730246